Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

VGX-100 enhances antitumor effects of bevacizumab/docetaxel in vivo

May 14, 2010

Viralytics set to meet with FDA to review proposed phase II melanoma study

May 14, 2010

UCB presents novel PI3K inhibitors

May 14, 2010

Novartis claims novel farnesyl pyrophosphate synthase inhibitors

May 14, 2010

Merck KGaA identifiies novel oral heat shock protein 90 inhibitors for cancer

May 14, 2010

Cell Therapeutics and NCCTG to conduct phase II study of pixantrone in metastatic breast cancer

May 13, 2010

Schering-Plough launches Temodal injection in Japan

May 13, 2010

FLT3/ITD kinase inhibitors ITRI-260 and ITRI-376 potential candidates for AML treatment

May 13, 2010

Promising preclinical effect of pan PI3Kalpha inhibitor NVP-BKM-120 disclosed

May 13, 2010

Quest PharmaTech doses first patient in prostate cancer trial

May 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...